To: Clappy who wrote (11211 ) 4/5/2000 7:39:00 PM From: Clappy Respond to of 35685
Biotechs led the Nasdaq into this tumble. Now they might be leading us out. My favorite biotech (who I sold yesterday in panic at $57) was up today 56%. It is sitting way up there at the $115 level. I sure can pick the bottoms... I'm not bitter though. I think these days are forever etched into my mind. I'm a new type of investor/trader now. The only problem is that I have to learn how this type of investor works and what makes him tick... JW, if you read this post, please give me some sort of TA on CRA. I would like to get back in, but not by paying this current price. Do you think it could drop the 3/8 that a lot of the big runs give back? I know many of you don't like this sector for valid reasons. However, I'm still convinced that this is the new frontier of tech stocks. It will also provide the high expectations and quick momentum rides that many of the burnt tech and internet investors will continue to crave. The sector is so much more than just patents on genes. It is, at least, worth a good amount of DD on a rainy day. A highly speculative sector? Yes. Very oversold sector? Yes. It appears to be the first to be rising from the ashes. This summer, the human genome will be finished being mapped by Celera. This data will be provided to research teams, biotechs and drug companies for free. However, CRA will sell the "smart" info and the shortcut through this maze. All of the race participants will be lined up to get the smart info so they can cross the finish line first to win claims to their particular patent. I believe Celera will have to search for the cure of "Money coming out of the Wazoo" for themselves... Dr.Clappy P.S. The above is just my humble opinion. As usual, do your own DD. ...and tell me what you think...